AZD0837
Sponsors
AstraZeneca
Conditions
HealthyNonvalvular Atrial FibrillationPersistent or Permanent Non-valvular Atrial FibrillationPersistent or Permanent Nonvalvular Atrial Fibrillation
Phase 1
Excretion of Radiolabelled AZD0837
CompletedNCT00812643
Start: 2009-01-31End: 2009-02-28Target: 8Updated: 2009-03-11
Effect of Ketoconazole on Biliary Excretion of AZD0837
CompletedNCT00812344
Start: 2008-12-31End: 2009-03-31Target: 20Updated: 2010-12-03
Pharmacokinetics of Extended-Release Test- and Reference Formulations of AZD0837
CompletedNCT00878618
Start: 2009-04-30End: 2009-05-31Target: 36Updated: 2009-06-03
AZD0837 Extended Release (ER) Japan Study
CompletedNCT00904800
Start: 2009-05-31End: 2009-06-30Target: 36Updated: 2009-07-13
Phase 2
Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA)
CompletedNCT00623779
Start: 2007-10-31End: 2008-10-31Updated: 2012-03-23
Long-term Safety in Atrial Fibrillation Patients
CompletedNCT00645853
Start: 2007-10-31End: 2009-05-31Updated: 2012-03-23
Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation
CompletedNCT00684307
Start: 2007-02-28End: 2008-06-30Updated: 2012-03-23